AI-derived left-to-right cardiac chamber volume ratios in coronary artery calcium scans strongly predict heart failure.
Authors:
Journal: European heart journal. Cardiovascular Imaging
Publication Type: Journal Article
Date: 2026
DOI: PMC13021276
ID: 41591983
Abstract
The AI-CVD initiative seeks to extract actionable insights from coronary artery calcium (CAC) scans beyond the traditional CAC score. We previously demonstrated that AI-derived cardiac chamber volumes from CAC scans predict incident heart failure (HF). We aimed to evaluate whether left-to-right cardiac chamber volume ratios outperform chamber volumes in predicting HF.
Reference List
- Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 2022;118:3272–87.|||Wei C, Heidenreich PA, Sandhu AT. The economics of heart failure care. Prog Cardiovasc Dis 2024;82:90–101.|||McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2023;44:3627–39.|||McCracken C, Szabo L, Abdulelah ZA, Condurache D-G, Vago H, Nichols TE et al. Ventricular volume asymmetry as a novel imaging biomarker for disease discrimination and outcome prediction. Eur Heart J Open 2024;4:oeae059. doi: 10.1093/ehjopen/oeae059.|||Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation 2023;148:1606–35.|||Naghavi M, Reeves A, Budoff M, Li D, Atlas K, Zhang C et al. AI-enabled cardiac chambers volumetry in coronary artery calcium scans (AI-CAC(TM)) predicts heart failure and outperforms NT-proBNP: the multi-ethnic study of atherosclerosis. J Cardiovasc Comput Tomogr 2024;18:392–400.|||Naghavi M, Mirjalili R, Atlas K, Zhang C, Reeves A, Atlas T et al. AI-enabled Cardiac chambers volumetry interactions with diabetes for incident heart failure: an AI-CVD study. J Cardiovasc Comput Tomogr 2025;19:S52.|||Naghavi M, Reeves AP, Atlas K, Zhang C, Atlas T, Henschke CI et al. Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction. NPJ Digit Med 2024;7:309.|||Naghavi M, Reeves Anthony P, Atlas Kyle C, Zhang C, Li D, Atlas T et al. AI-Enabled CT cardiac chamber volumetry predicts atrial fibrillation and stroke comparable to MRI. JACC Adv 2024;3:101300.|||Naghavi M, Yankelevitz D, Reeves AP, Budoff MJ, Li D, Atlas K et al. AI-enabled left atrial volumetry in coronary artery calcium scans (AI-CAC(TM)) predicts atrial fibrillation as early as one year, improves CHARGE-AF, and outperforms NT-proBNP: the multi-ethnic study of atherosclerosis. J Cardiovasc Comput Tomogr 2024;18:383–91.|||Razipour A, Grodecki K, Manral N, Geers J, Gransar H, Shanbhag A et al. AI-derived automated quantification of cardiac chambers and myocardium from non-contrast CT: prediction of major adverse cardiovascular events in asymptomatic subjects. Atherosclerosis 2025;401:119098.|||Miller RJH, Killekar A, Shanbhag A, Bednarski B, Michalowska AM, Ruddy TD et al. Predicting mortality from AI cardiac volumes mass and coronary calcium on chest computed tomography. Nat Commun 2024;15:2747.|||Hoballah M, Chehab O, Abdollahi A, Wu Colin O, Scarpa B, Post Wendy S et al. Left-to-right cardiac chamber volume ratios as predictors of cardiovascular events: the multi-ethnic study of atherosclerosis (MESA). JACC 2025;85:2109.|||von Knobelsdorff-Brenkenhoff F, Pilz G, Schulz-Menger J. Representation of cardiovascular magnetic resonance in the AHA/ACC guidelines. J Cardiovasc Magn Reson 2017;19:70.|||Naghavi M, Reeves A, Atlas K, Zhang C, Roy S, Budoff M et al. Automated left ventricular volumetry using artificial intelligence in coronary calcium scans (AI-CAC) predicts heart failure comparably to cardiac MRI and outperforms NT-proBNP: the multi-ethnic study of atherosclerosis (MESA). J Cardiovasc Comput Tomogr 2024;18:S16–7.|||Naghavi M, Atlas K, Zhang C, Reeves A, Jaalouk E, Henschke C et al. AI-enabled Cardiac chambers volumetry in non-contrast cardiac CT scans (AI-CAC) detects HFrEF vs. HFpEF. Circulation 2024;150:A4144057–A.|||Bild DE, Bluemke DA, Burke GL, Detrano R, Roux D, Folsom AV et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002;156:871–81.|||Bittencourt MS, Blankstein R, Mao S, Rivera JJ, Bertoni AG, Shaw LJ et al. Left ventricular area on non-contrast cardiac computed tomography as a predictor of incident heart failure—the Multi-Ethnic Study of Atherosclerosis. J Cardiovasc Comput Tomogr 2016;10:500–6.|||Kannel WB, Feinleib M, Mcnamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the framingham offspring study. Am J Epidemiol 1979;110:281–90.|||Liu CT, Broe KE, Zhou Y, Boyd SK, Cupples LA, Hannan MT et al. Visceral adipose tissue is associated with bone microarchitecture in the framingham osteoporosis study. J Bone Miner Res 2017;32:143–50.|||McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the framingham study. N Engl J Med 1971;285:1441–6.|||Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A et al. Development and validation of the American Heart Association’s PREVENT equations. Circulation 2024;149:430–49.|||Khan SS, Coresh J, Pencina MJ, Ndumele CE, Rangaswami J, Chow SL et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association. Circulation 2023;148:1982–2004.|||Drowatzky KL, Durstine JL, Irwin ML, Moore CG, Davis PG, Hand GA et al. The association between physical activity, cardiorespiratory fitness, and lipoprotein(a) concentrations in a tri-ethnic sample of women: the Cross-Cultural Activity Participation Study. Vasc Med 2001;6:15–21.|||Ekelund U, Steene-Johannessen J, Brown WJ, Fagerland MW, Owen N, Powell KE et al. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. Lancet 2016;388:1302–10.|||Ozemek C, Bonikowske A, Christle J, Gallo P. ACSM's Guidelines for Exercise Testing and Prescription. Philadelphia: Lippincott Williams & Wilkins; 2025.|||Asch FM, Miyoshi T, Addetia K, Citro R, Daimon M, Desale S et al. Similarities and differences in left ventricular size and function among races and nationalities: results of the world alliance societies of echocardiography normal values study. J Am Soc Echocardiogr 2019;32:1396–406.e2.|||Yates T, Razieh C, Henson J, Rowlands AV, Goldney J, Gulsin GS et al. Device-measured physical activity and cardiac structure by magnetic resonance. Eur Heart J 2024;46:176–86.|||Galderisi M, Cardim N, D'Andrea A, Bruder O, Cosyns B, Davin L et al. The multi-modality cardiac imaging approach to the Athlete's heart: an expert consensus of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16:353.|||Flanagan H, Cooper R, George KP, Augustine DX, Malhotra A, Paton MF et al. The athlete’s heart: insights from echocardiography. Echo Res Pract 2023;10:15.|||Dong T, Wang TKM. Nuances in defining normal ranges for chamber quantification with cardiovascular magnetic resonance. Circ Cardiovasc Imaging 2024;17:e016488.|||Arbab-Zadeh A, Dijk E, Prasad A, Fu Q, Torres P, Zhang R et al. Effect of aging and physical activity on left ventricular compliance. Circulation 2004;110:1799–805.|||Diaz-Canestro C, Montero D. The impact of sex on left ventricular cardiac adaptations to endurance training: a systematic review and meta-analysis. Sports Med 2020;50:1501–13.